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Abstract
Background: Disparities in cancer incidence and mortality rates between regions arise due to differences in
socioeconomic conditions and in human development factors. The major purpose of this study was to measure
the role of the Human Development Index (HDI) in the pattern of cervical cytological abnormalities (CCAs).
Methods: This was an analytical sectional study involving a review of secondary cervical cytology data collected from
women living in the state of Maranhão, Brazil, in 2007–2012 and collected from the Cervical Cancer Information System
(Sistema de Informação do Câncer do Colo do Útero - SISCOLO). The cervical screening results were classified
according to the Brazilian Classification of Cervical Reporting (Nomenclatura Brasileira para Laudos Cervicais), an
adaptation of the Bethesda System. The Municipal Human Development Index (MHDI) was used, which is an
adaptation of the global HDI. The association between CCAs and MHDI was evaluated using the chi-squared test and
odds ratios (ORs) with 95 % confidence intervals (95 % CI). The significance level used for all tests was 5 %.
Results: We analysed 1,363,689 examinations of women living in the state of Maranhão. CCAs were identified in 2.0 %
of smears in municipalities with high MHDI, 2.2 % in those with medium or low MHDI and 4.1 % in those with very low
MHDI. In addition, potentially malignant changes and suspected cervical cancer (HSIL+) were 40.0 % more frequent
(0.3 %) in municipalities with medium or low MHDI and 3.6 times more frequent (0.8 %) in municipalities with very low
MHDI compared to those with high MHDI (0.2 %).
Conclusion: The association between MHDI and the occurrence of CCAs and HSIL+ shows that more developed areas
with more effective health services have a lower prevalence of these lesions. To control cervical cancer, it is necessary
to reduce social inequality and improve the availability of health services.
Keywords: Cervical cancer, Human development index, Health status disparities, Cytological Abnormalities,
Cancer precursor lesions, Brazil
Background
Cervical cancer is the fourth-most common cancer in
women, with 528,000 new cases annually and 266,000
deaths in 2012. It has become a major public health
problem [1]. In Brazil, the estimate for 2016 is 16,340
new cases with an risk of 15.85 cases per 100,000
women, which would make it the third-most common
cancer in the female population. It contributes to the
high female mortality rate in the country, and in some
regions, it is the leading cause of cancer death [2]. For
the state of Maranhão, located in the northeast of Brazil,
it has been estimated that in 2016, cervical cancer will
be the most common gynaecological cancer, with 28.57
new cases per 100,000 women, one of the highest
estimated incidence rates in Brazil. It is important to
highlight the real possibility of underestimation, espe-
cially in municipalities other than the capital of the state,
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which historically tend to underreport data, as 23.7 % of
expected cases are found in the capital São Luís, with an
estimated crude incidence rate of 42.58/100,000 women
[2]. In addition, the mortality rate for this cancer adjusted
for the world population in 2012 (last year with available
data) was 10.22 per 100,000 women, and it remained above
9.00 per 100,000 women between 2005 and 2011 [3].
In Brazil, cervical cancer screening programs are based
on Pap smear testing. Smears are read in a large number
of laboratories by certain professional groups such as
physicians (cytopathologists and pathologists), pharma-
cists, biologists, biomedical scientists or cytotechnolo-
gists. Defined standards and criteria are used to measure
the quality of cytopathology testing and to assess the
performance of public and private laboratories providing
services to the Brazilian Unified Health System (Sistema
Único de Saúde – SUS).
The high incidence and mortality, principally in less
developed regions [1], reveals inequalities between differ-
ent socioeconomic groups and exposure to risk factors
present in these areas. Its occurrence stems from poor
living conditions [4], such as a lack of, or difficulty of
access to, health services, especially population screening
programs [5]. From this perspective, the United Nations
Human Development Index (HDI) is a good indicator for
better understanding how these underlying causes may
contribute to differences in the geographical and temporal
distribution of risk factors and to determine occurrence
patterns of this cancer. This is justified by the fact that the
HDI, a summary measure of human development, incor-
porates primordial human development dimensions such
as long and healthy life (based on life expectancy at birth),
access to knowledge (based on a combination of adult
literacy rate and primary education to tertiary education
enrolment rates) and decent living standards (based on
Gross National Product - GDP per capta adjusted for
purchasing-power parity). In that regard, it can be seen as
an indirect indicator of adverse living conditions, given
that 69.7 % of new cases and 74.9 % of deaths from
cervical cancer occur in less developed countries with
medium or low HDI [1]. Following this trend, mortality
from this cancer in Brazil is more frequent in socio-
economically disadvantaged regions [6, 7]. In the highest
HDI regions of the world, the cancers of the female breast,
lung, colorectum, and prostate were the most common,
whereas in medium HDI regions, the cancers of the
oesophagus, stomach, and liver were the predominant
forms, and in low HDI regions, cervical cancer was more
common [8]. Against this backdrop, and considering that
the prevention and control of cervical cancer is predicated
on routine cervical screening, a strategy known to be
effective in fighting the problem, it is important to know
the profile of cervical screening conducted in the state of
Maranhão. The results can contribute to the adoption of
public policies with greater efficiency and that are more
locally appropriate in combating a disease that at least in
theory should be easily avoidable. This will enable us to
qualify the situational diagnosis and to create interven-
tions that increase screening efficiency. Although the state
of Maranhão occupies the penultimate place in the HDI
ranking of Brazilian states, there is heterogeneous
resource distribution, and living condition indicators vary
widely among its municipalities [9]. This study is therefore
justified in order to identify, for the first time in a Brazilian
state, the role of the Human Development Index (HDI) in
the pattern of CCAs.
Methods
This was an analytical sectional study with a review of
secondary cervical cytology data performed on women liv-
ing in the state of Maranhão in 2007–2012 and collected
from the Cervical Cancer Information System (Sistema de
Informação do Câncer do Colo do Útero - SISCOLO).
This system was established by the Ministry of Health of
Brazil in 1999 to assist in the reimbursement of exams
and monitoring and evaluation of the Brazilian Cervical
Cancer Early Detection Program (Programa Nacional de
Controle do Câncer de Colo do Útero - PNCCCU) activ-
ities. The database was made available electronically by
the Health Secretariat of the State of Maranhão. The data,
originally organised into monthly files, were exported into
a Data Base File (DBF) format and aggregated into a
single database in Microsoft Excel 2010. From a total of
1,368,891 cervical screenings, 5,202 (0.4 %) identified as a
“rejected sample” were excluded.
The variables analysed were age, place of residence,
previous cervical screening and time since last cervical
screening. The cervical screening results were classified
according to the Brazilian Classification of Cervical
Reporting [10], an adaptation of the Bethesda System
adopted in the country since April 2006 on the recom-
mendation of the Ministry of Health. The smears were
analysed regarding adequacy of the sample, presence or
absence of the transformation zone (TZ) component and
presence of atypical cells. In this study, the presence of an
adequate number of metaplastic and/or glandular epithelia
on the examined material were considered representative
of TZ epithelia [11]. The examinations were classified as
within normal limits, benign cellular changes (inflamma-
tion, repair, immature squamous metaplasia, atrophy with
inflammation, radiation, etc.) or atypical cells. Atypical
cells were classified as atypical cells of undetermined
significance (atypical squamous cells [ASC], atypical
glandular cells [AGC] or of unknown origin), atypical
squamous cells (low-grade squamous intraepithelial lesion
[LSIL], comprising cytopathic effect by human papilloma-
virus [HPV] and grade I cervical intraepithelial neoplasia;
high-grade squamous intraepithelial lesion [HSIL],
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including grades II and III cervical intraepithelial neopla-
sia; HSIL not excluding micro-invasion; squamous cell
carcinoma [SCC]); atypical glandular cells (adenocarcin-
oma in situ [AIS]; and invasive adenocarcinoma [IA]).
Potentially malignant changes and suspected cervical
cancer (HSIL, SCC, AIS e IA) were grouped as HSIL+.
The Municipal Human Development Index (MHDI) for
the woman’s place of residence was used. The MHDI is an
adaptation of the global HDI, adjusted for national indica-
tors [9]. The MHDI adjusts the HDI to the municipal real-
ity and reflects specific and regional challenges in
Brazilian human development. The MHDI assesses the
same dimensions as the global HDI – health, education
and income – however, some of the applied indicators are
different. The MHDI also varies between 0 (minimum
value) and 1 (maximum value). The municipalities were
classified as high MHDI (0.700 to 0.799), medium MHDI
(0.600 to 0.699), low MHDI (0.500 to 0.599) and very low
MHDI (0.400–0.499). Medium and low MHDI were
grouped into a single category based on their distribution
in regard to other study variables.
Statistical analysis was performed using IBM SPSS
Statistics software, version 20. The chi-squared test was
applied to compare categorical variables. Odds ratios
(OR) and their respective 95 % confidence intervals
(95 % CI) were also calculated. The significance level
used for all tests was 5 %.
To estimate failure in the detection process due to a
lack of TZ-representative cellular elements, the number
of unidentified cervical cancer and precursor lesions was
calculated according to the following Eq:





Where plpcani represents the number of non-
identified potentially malignant changes and suspected
cervical cancer; OR tz represents the OR found regarding
the association of precursor and cervical cancer-
suspicious lesions among the groups with smears with
and without TZ representativeness; and lpcai
s= tz
repre-
sents the total number of cervical cancer and precursor
lesions detected in smears with no TZ cells.
The research project was approved by the Research Eth-
ics Committee of the Federal University of Maranhão N.
045181/2013, as per the National Council of Health Reso-
lution number #466/2012. Written informed consent was
not required due to the observational nature of the study.
Results
We analysed 1,363,689 samples of women living in the
state of Maranhão. The capital of the state, São Luís,
contributed with 21.5 % of patients; 68.7 % were from
municipalities with medium or low MHDI, 31.0 % from
municipalities with high MHDI and 0.3 % from
municipalities with very low MHDI. The age varied from
12 to 99 years, with 76.3 % of tests in women aged 25 to
64 years, 19.9 % inwomen under the age of 25 years and
3.8 % inwomen aged over 65 years. Tests were being
performed for the first time in 16.9 % of cases. Previous
cervical screening was reported by women in 61.0 % of
cases. Of these, 65.5 % were performed after an interval
since the previous test of up to 3 years (Table 1).
Among the 1,327,691 tests considered satisfactory for
cytological evaluation (97.4 % of total), only 58.8 % had TZ-
representative epithelia, 2.2 % had atypical cells, and the
rest (97.8 %) were characterised as within normal limits or
with benign cellular changes. Atypical cells were identified
in 2.0 % of smears in municipalities with high MDHI, 2.2 %
in those with medium or low MHDI and 4.1 % in those
with very low MHDI. Atypical squamous cells of undeter-
mined significance were identified in 1.1 % of cytological
smears, LSIL in 0.8 % and HSIL in 0.3 %. Atypia suggestive
of HSIL+ were observed in 0.3 % of all analysed tests. The
percentage of satisfactory smears in municipalities with
high, medium or low and very low MHDI was 98.2, 97.0
and 98.8 %, respectively. However, TZ representativeness,
the prevalence of atypical cells and HSIL+ prevalence were
inversely proportional to MHDI (Table 2).
The women’s mean age was 36.8 (±13.6) years. There
was an age variation according to the citological anorm-
ality: 32.5 years (± 11.6) for cases of LSIL, 45.3 years (±
14.1) for cases of HSIL and 56.1 years (± 15.1) for cases
suspected of SCC (Fig. 1).
The chance of detecting any atypia increased three
times when there was TZ representativeness and by
20.0 % when the woman reported having been screened
previously or when time since the last test was more
than three years (Table 3). The chance of detecting LSIL
increased by 3.8 times with TZ representativeness in the
smear, increased by 20.0 % when the last examination
was more than 3 years ago and decreased by 10.0 % in
women who had had a prior examination (Table 3). The
chance of detecting HSIL+ increased 2.7 times when
there was TZ representativeness and 20.0 % when the
last examination was more than 3 years ago and when
the woman had been screened previously. Using the
PNCCCU prioritary age group as a reference, i.e., age 25
to 64, there was a decrease of 10.0 and 80.0 %, respect-
ively, in the chance of detecting any atypia and detecting
HSIL+ in the age group less than 25 years and, at the
same time, an increase of 50.0 % in the chance of detect-
ing LSIL in the same age group. On the other hand, for
the ≥65-year age group, there was a 50.0 % decrease in
the chance of detecting LSIL, while there was an
increase of 40.0 and 180 %, respectively, in the chance of
detecting any atypia or HSIL+ (Table 3).
The stratified analysis by age group showed that
women between 25 and 64 years (OR = 0.9) and those ≥
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65 years (OR = 0.8) were less likely to have cervical cancer
and precursor lesions when they had had previous cervical
screening. In contrast, in women under 25 years of age,
having undergone previous screening increased the
chance of detection of these lesions by 60 % compared to
women who had not been screened previously (OR = 1.6)
(Table 4). The number of unidentified cervical cancer and
precursor lesions was estimated for 1,357 cases due to a
lack of TZ-representative cellular elements. Finally, the
chance of detection of cervical cancer and precursor
lesions increased by 40.0 % in municipalities with medium
or low MHDI and 3.6 times in municipalities with very
low MHDI compared to those with high MHDI (Table 5).
Discussion
The profile of the study population was women who
spontaneously approached the public health system
(SUS) seeking cervical screening. The majority lived in
municipalities with medium or low MHDI (68.7 %),
although the capital, São Luís, with the highest index in
the state, contributed to a considerable number of cases
(21.5 %). The results of this study showed that there was
a close association between MHDI and detection of cer-
vical cancer and precursor lesions. To our knowledge,
this is the first study to investigate this association.
The high demand for tests by women in the 25-64-year
age group (76.3 %), which is the age group at the highest
risk for cervical cancer, is in keeping with the Brazilian
Guidelines for Cervical Cancer Screening [11], which
recognises this as the target population of the screening
program. In line with this recommendation, 84.5 % of
cervical cancer and precursor lesions were described in
this age group. A study conducted in 2011 in two Brazilian
municipalities with different socioeconomic characteris-
tics, Rio de Janeiro in the southeast region and Maceió in
the northeast region, showed that the percentage of tests
in the 25–64 year age group was 78.1 and 74.7, respect-
ively, with a predominance of younger women in Rio de
Janeiro and older in Maceió [12]. Another study
conducted in the state of Maranhão analysing the 139,505
cervical screenings performed during 2011 showed that
76.8 % were women aged 25–64 [13].
In accordance with the recommendations from the
Brazilian Guidelines [11], this study showed that in most
cases (58.8 %), women have exams at intervals of less
than three years. Higher rates were observed in Maceió
(68.8 %) and Rio de Janeiro (74.3 %) [12]. In another
study involving women living in 13 communities located
in Baixada Fluminense, on the outskirts of the state
capital of Rio de Janeiro, 70.7 % of women had up-to-
date screening [14]. Note that annual repetition of the
examination, which occurred in 41.1 % of cases, does
not increase the protective effect of screening [15]. At
the other extreme, when the recommended three-year
interval was exceeded, there was an increase of 17.0 % in
the chance of presenting atypia, 15.0 % of LSIL and
22.0 % of HSIL+. These data regarding age and fre-
quency of cervical screening indicate irregular access to
tests and an overloading of the health care system with
unnecessary consumption of resources.
The percentage of unsatisfactory smears for cytological
evaluation in this study (2.6 %) is within the minimum
quality standard established by the Ministry of Health,
which is up to 5.0 % [16]. Similar figures were observed
in a study conducted in the city of Goiânia, located in
the Midwestern region of the country, in which, from a
total of 10,951 smears, 2.3 % were classified as unsatis-
factory [17]. However, this is well above the percentage
Table 1 Sociodemographic characteristics of women





25 to 29 214.668 15.7
30 to 34 195.841 14.4
35 to 39 165.181 12.1
40 to 44 140.481 10.3
45 to 49 119.722 8.8
50 to 54 95.378 7.0
55 to 59 67.114 4.9
60 to 64 42.102 3.1
>64 51.923 3.8
Prior preventive exam
Never done 231.132 16.9
Done previously 832.322 61.0
Missing 300.235 22.0
Time since last exama
≤ 1 year 342.362 41.1
2 years 147.032 17.7
3 years 55.724 6.7




Other municipalities 1.070.770 78.5
MHDI of woman’s place of residence
High 423.202 31.0
Medium or low 936.038 68.7
Very low 4.449 0.3
Total 1.363.689 100.0
aOnly for those who already had prior screening
MHDI Municipal Human Development Index
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found in Brazil, in 2002, in a study involving 739 labora-
tories and 10,505,773 cervical cytology screenings, of
which 1.6 % were considered unsatisfactory; 25.0 % of
the laboratories analysed (25th percentile) had more
than 2.0 % of unsatisfactory samples [18]. More recently,
a profile analysis of cervical-uterine cytology laboratories
showed that of 10,275,476 tests performed in the
Brazilian public health system in 2010, only 1.0 % were
considered unsatisfactory [19]. In Maceió and Rio de
Janeiro the percentages of unsatisfactory examinations
were 0.4 and 0.2 %, respectively [12].
Several studies have confirmed the association be-
tween TZ epithelial representativeness, an indicator of
specimen collection quality, and the detection of cyto-
logical abnormalities, and an association between the
lack of these cells and limitations in sample analysis with
high rates of false-negative results [17, 20]. In this study
TZ representativeness proved to be very weakened in
that only 58.8 % of the collected samples showed it. In
fact, the results presented here indicate a greater chance
of identifying any atypia (OR = 3.0), LSIL (OR = 3.8) and
HSIL+ (OR = 2.8) in the presence of TZ-representative
cell groups. In São Paulo, a review of 24,316 cervical
screening reports conducted between January 2005 and
December 2008 in a single pathology laboratory showed
that among patients who were younger than 40 years,
88.8 % had TZ material in their smears, as opposed to
only 53.0 % of those aged 40 or more [21]. A lack of TZ
representativeness has contributed, at least in part, to
the low sensitivity of the screening process in detecting
citological abnormalities in the population examined in
the present study, and this was mirrored by the positivity
rate. This result allowed us to estimate that the screen-
ing program during this period failed to identify 26.1 %
(1,357/5,198) of HSIL+ lesions. Note that it is precisely
on the basis of correct identification of potentially malig-
nant lesions that the screening program can reduce the
incidence and mortality from this cancer. Thus, the low
TZ representativeness identified, despite not having been
corrected for potentially confounding variables such as
age, hormonal influence and previous hysterectomy,
demonstrates the need for training in proper in smear
collection, preparation and examination. Furthermore,
this points to the need for constant monitoring, which is
critical in providing women with the benefits of cervical
cancer screening and in avoiding wasting resources and
the adverse effects of false-negative results.
The positivity index, which expresses the frequency of
atypical cells in satisfactory exams, was lower (2.2 %)
than the 3.0–10.0 % expected by Brazilian Guidelines
[19]. Other studies conducted in the country, in Goiás
(6.1 %) [17] and in Rio de Janeiro (6.8 %) [12], showed
values above 6 %. However, in Maceió only 1.1 % of tests
were abnormal [12]. In Spain, the percentage of cytology
positivity (any atypia) increased from 3.0 % in 2008 to
Table 2 Cervical cytopathology exams performed in the state of Maranhão, Brazil. 2007 to 2012
Variables High MHDI Medium or low MHDI Very low MHDI Total
N % N % N % N %
Sample adequacy
Unsatisfactory 7,565 1.8 28,378 3.0 55 1.2 35,998 2.6
Satisfactory 415,637 98.2 907,660 97.0 4,394 98.8 1,327,691 97.4
Transformation zone
Absent 175,332 57.8 370,796 40.9 879 20.0 547,007 41.2
Present 240,305 42.2 536,864 59.1 3,515 80.0 780,684 58.8
Cervical screening diagnosisa
Within normal limits or with benign abnormalities 407,253 98.0 887,565 97.8 4,214 95.9 1,299,032 97.8
Cellular atypiaa 8,384 2.0 20.095 2.2 180 4.1 28,659 2.2
Atypical cells of undetermined significancea 3,005 0.7 11,433 1.3 49 1.1 14,487 1.1
Low-grade squamous intraepithelial lesion (LSIL)a 4,429 1.1 5,735 0.6 95 2.2 10,259 0.8
High-grade intraepithelial lesion or worse (HSIL+)a 950 0.2 2,927 0.3 36 0.8 3,913 0.3
aOnly for satisfactory samples
MHDI Municipal Human Development Index, TZ transformation zone
Fig. 1 Mean age (±Standard Deviation) according to the citological
anormality. State of Maranhão, Brazil. 2007 to 2012
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3.5 % in 2011 [22]. In countries like England, the United
States and Norway, which have well-structured cyto-
logical screening programs, the positivity rates were
5.9 % [23], 4.3 % [24] and 5.7 % [25], respectively. Re-
cently, liquid-based cytology specimens from 46,887
women ≥ 21 years of age from 61 centers in 23 states
across the United States were evaluated in the ATHENA
trial, and the overall cytological abnormal rates ranged
from 3.8 to 9.9 % [26].
The HSIL+ percentage of 0.3 % proved consistent with
that observed in 2010 in Brazil (0.3 %) [18]. In a previ-
ous study, the prevalence of cervical cytopathological
lesions was significantly different between Brazilian
regions. While no objective information can justify this
difference, some authors hypothesize that there may be
a difference in the diagnostic performance of the screen-
ing, related to the quality of the Pap smear [27]. In
England, the United States and Norway, cervical cancer
Table 3 Variables associated with the presence of any atypia, LSIL or HSIL+ in cervical cytopathology exams. State of Maranhão,
Brazil. 2007 to 2012
Variables Yes No OR 95 % CI p-value
n % n %
Any Atypia
Age < 25 years vs. 25 to 64 years 5,186 2.0 260,215 98.0 0.9 0.89–1.95 <0.001
Age ≥ 65 years vs. 25 to 64 years 1,467 3.0 48,005 97.0 1.4 1.34–1.49 <0.001
Presence vs. absence of TZ 22,615 2.9 758,069 97.1 3.0 2.86–3.03 <0.001
Already had prior exam vs. Never had 16,896 2.0 815,426 98.0 1.2 1.11–1.19 <0.001
Time since last screening > 3 years vs. ≤ 3 years 1,127 2.3 47,581 97.7 1.2 1.10–1.24 <0.001
LSIL
Age < 25 years vs. 25 to 64 years 2,881 1.1 262,520 98.9 1.5 1.47–1.60 <0.001
Age ≥ 65 years vs. 25 to 64 years 172 0.3 49,300 99.7 0.5 0.43–0.58 <0.001
Presence vs. absence of TZ 8,651 1.1 772,033 98.9 3.8 3.60–4.02 <0.001
Already had prior exam vs. Never had 5,237 0.6 827,085 99.4 0.9 0.86–0.96 0.001
Time since last screening > 3 years vs. ≤ 3 years 361 0.7 48,347 99.3 1.2 1.03–1.28 0.015
HSIL+
Age < 25 years vs. 25 to 64 years 157 0.1 265,244 99.9 0.2 0.16–0.22 <0.001
Age ≥ 65 years vs. 25 to 64 years 438 0.9 49,034 99.1 2.8 2.51–3.07 <0.001
Presence vs. absence of TZ 3,043 0.4 777,641 99.6 2.7 2.48–2.90 <0.001
Already had prior exam vs. Never had 2,305 0.3 830,017 99.7 1.2 1.06–1.27 0.002
Time since last screening > 3 years vs. ≤ 3 years 163 0.3 48,545 99.7 1.2 1.04–1.44 0.016
OR odds ratio, 95 % CI, 95 % confidence interval, TZ, transformation zone
LSIL Low-grade squamous intraepithelial lesion, HSIL+ high-grade squamous intraepithelial lesionor worse
Table 4 Association between having had prior screening and the presence of HSIL+ (squamous or glandular) stratified by age
group. State of Maranhão, Brazil. 2007 to 2012
Had prior screening Yes No OR 95%CI p-value
n % n %
< 25 years
No 35 0.0 87,362 100.0 Reference
Yes 74 0.1 113,252 99.9 1.6 1.09–2.44 < 0.001
25–64 years
No 436 0.3 129,731 99.7 Reference
Yes 1,992 0.3 665,237 99.7 0. 9 0.80–0.98 < 0.001
≥65 years
No 81 1.1 7,570 98.9 Reference
Yes 239 0.8 29,502 99.2 0.8 0.59–0.97 < 0.001
OR odds ratio, 95%CI 95 % confidence interval
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precursor lesions constituted 1.0 % [22], 0.5 % [23] and
0.8 % [25], respectively. It should be noted that in Rio de
Janeiro this percentage was 0.9 %, in contrast to Maceio,
where the percentage of HSIL+ was 0.1 % [12].
Considering the high incidence of cervical cancer in
the state of Maranhão and the low positivity of cervical
screening for any atypia and for HSIL+, one can specu-
late that suspicious abnormalities were not being identi-
fied, which may have led to false-negative results. It is
therefore important to evaluate and enhance the moni-
toring of both the pre-analytical phase of smear reading
(mainly collection errors) and the analytical phase (scru-
tiny and interpretation errors).
Pap abnormal rates lower than those described by
other studies may have been influenced by events such
as inappropriate sample collection or slide preparation,
difficulty in the detection of intraepithelial lesions by the
professional as a consequence of suboptimal slide prep-
aration, or high workload routine or inadequate training,
resulting in the need for continued education of the pro-
fessionals involved in all stages of screening.
The natural history of cervical cancer was replicated in
the results found for the average age of women accord-
ing to cytological atypia in squamous cell diagnoses,
demonstrating its evolutionary character, with an inter-
val between LSIL and HSIL of 12.8 years and between
HSIL and SCC of 10.8 years. The classical model of the
natural history of cervical carcinoma proposed by the
World Health Organization more than 25 years ago esti-
mated that time to progression of grade I and II cervical
intraepithelial neoplasia to grade III intraepithelial cer-
vical neoplasia is 3–8 years, while it would take 10–15
years between grade III cervical intraepithelial neoplasia
and microinvasive carcinoma [28]. To that end, the ana-
lysis of stratification by age group, considering the range
of 25–64 years as a reference, identified a statistically
significant increase in LSIL detection before 25 years of
age (OR = 1.5) and in cervical cancer and precursor le-
sions in the >64-year old group (OR = 2.8). These results
confirm what was already expected, that is, before
25 years of age LSIL prevails, but regress spontaneously
in most cases [29, 30]. On the other hand, in women
over 64 years, the incidence of cervical cancer and
precursor lesions probably reflects the lack of previous
cytology and/or poor quality of the previous screening.
In fact, the positive preventive effect was demonstrated
clearly in women who had undergone screening at least
once among those aged 25–64 years and those aged
≥65 years, who had, respectively, a 10.0 % (OR = 0.9) and
a 20.0 % (OR = 0.8) lower chance of having cervical can-
cer and precursor lesions. This trend continued regard-
less of age, as the prevalence of cervical cancer and
precursor lesions was also significantly lower in women
who reported having previous cervical screening. In
other words, not having been screened, especially in the
>25 age group, significantly increased the chance of hav-
ing cervical cancer and precursor lesions. Thus, we can
hypothesize that deficiencies in the coverage of screen-
ing in the state of Maranhão’s population has resulted in
high cervical cancer incidence rates.
However, it is noteworthy that prior screening did not
increase the chance of detection of LSIL. To better
explain this occurrence, the quality of examinations per-
formed, their frequency and the follow-up of women
would need to be investigated. It may be inferred in the
meantime that this could partly be due to the fact that it
is a transient and self-limiting form of colpocytological
change, which is expected to exhibit spontaneous regres-
sion in most cases [29, 30]. Another possibility might be
the limitations of the exam itself, which is affected by
the low rate of positivity and lack of representativeness
of TZ epithelia found in many cases.
Cervical cancer incidence is inversely associated with
HDI, as it is the most common cancer in low-HDI re-
gions and is the cancer with the highest incidence and
greatest mortality in women in several countries with
medium and low HDI [8]. Similarly, the association be-
tween MHDI and the presence of cervical cancer and
precursor lesions in Maranhão state was significant. The
prevalence of these lesions also demonstrated a tendency
to increase as MHDI decreases. Thus, municipalities
with medium or low MHDI and with very low MHDI
had 40.0 and 260 % more detected lesions, respectively,
than municipalities with high MHDI. The state of Mar-
anhão has considerable variation of MHDI among its
municipalities, with rates ranging from 0.443 in the mu-
nicipality of Fernando Falcão (the second-lowest of
Brazil) to 0.724 in the capital São Luís [9]. These varia-
tions reflect existing differences related to access to
health services, education and income distribution, i.e.,
the quality and living conditions of the population in
these geographical areas.
In samples in municipalities with very low MHDI,
there was higher TZ representativeness, of the order of
80.0 % as opposed to 59.1 and 42.2 % found in munici-
palities with medium or low MHDI and in municipalities
with high MHDI, respectively. This fact suggests a
Table 5 Association between Municipal Human Development
Index (MHDI) and the presence of HSIL+ (squamous or glandular).
State of Maranhão, Brazil. 2007 to 2012
MHDI Yes % No % OR 95 % CI p-value
High 930 0.2 414.707 99.8 Reference
Medium or
low
2.875 0.3 904.785 99.7 1.4 (1.30–1.50) < 0.001
Very low 36 0.8 4.358 99.2 3.6 (2.65–5.17) < 0.001
OR odds ratio, 95% CI 95 % confidence interval
MHDI Municipal Human Development Index
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higher rate of cervical cancer and precursor lesions,
which is presumed to stem from better technical prepar-
ation of the professionals performing the smear collec-
tion, as these are municipalities with fewer health units
and lower treatment volumes.
Similar studies of HDI association were not identified,
which precluded comparison with the results of this
study. However, HDI was associated with cancer progno-
sis (measured by years of life lost) in a study sponsored
by the International Agency for Research on Cancer
(IARC) involving 184 countries [31]. An increase of 0.2
in HDI was associated with a 20 % decrease in the risk
of developing cervical cancer and a 33 % decrease in the
risk of dying from this type of cancer [32]. Another
study involving 28 countries of the Pan American Re-
gion showed that HDI was inversely associated with the
incidence of and mortality from cervical cancer [33]. An
ecological study assessed the association of cervical can-
cer screening rates (Pap smear) with the HDI in the Bra-
zilian state capitals and Federal District. The results
pointed towards a positive correlation between HDI and
having a Pap smear any time in life or in the previous
three years (r = 0.66 and 0.71, respectively) [34].
Despite the profile of economic equity that can be
intuited between women seen within the public health
system in the state of Maranhão, this spatial delimitation
by MHDI allowed a more specific demonstration of a
strong social inequality regarding the chances of detect-
ing cervical cancer and precursor lesions. Women living
in regions with fewer essential quality-of-life conditions,
or even devoid of them, may have had greater suscepti-
bility to cervical cancer risk factors. On the other hand,
the results also clearly indicate that early cytological
diagnosis of atypia depends not only on human develop-
ment conditions but also on screening quality. This is
what was found in municipalities with very low MHDI,
which had better screening performance indicators,
which can be inferred from the lower percentage of un-
satisfactory cytologies and the higher percentage of TZ
representativeness in the samples. In that regard, the as-
sociation between the high quality of population screen-
ing programs and the decrease in incidence of and
mortality from cervical cancer is supported [35], and this
outcome might be projected for the coming decades
with improvement in quality life in poor countries [8].
This study has some limitations that must be consid-
ered in order to properly interpret its findings. First, a
large secondary database was analysed, with more than
one million cases, and data were collected over six years
from numerous health professionals, in different cities of
the state, which may have compromised the quality of
information and adherence to the PNCCCU protocols.
Important information such as the education level and
socioeconomic status of the women were not available
or were seldom complete and were excluded from the
analysis. In addition, the absence of a unique identifier
for the women may have allowed a single woman to be
included more than once in the study, preventing exact
measurement of the annual prevalence of cervical cancer
and precursor lesions in the population. However, the
percentage of smears with cervical cancer and precursor
lesions may be used as a proxi capable of helping in the
planning of disease control measures and attracting
women who would otherwise not obtain a test. Further-
more, the populational nature of the study, its size and
the internal consistency of the observations are strong
points to consider.
The findings of this study has as its greatest implication
the identification, for the first time in a Brazilian state, the
role of MHDI in the pattern of cervical cytological abnor-
malities (CCAs). When considering the MHDI as a vari-
able, we can even understand specific peculiarities and
differences of this association within the same State. Our
results certainly will provide subsidies to better qualify the
screening program for cervical cancer in that State.
The incorporation of MHDI in this study has identified
in its results the existence of inequity in the secondary pre-
vention of cervical cancer even in a poor Brazilian State.
Such evidence shows the need to incorporate strategies that
stimulate socioeconomic development of the counties in a
shared way with the Public Health policies providing an or-
ganized and qualified cytological screening.
Conclusion
This analysis enabled better evaluation of the perform-
ance of the National Program for the Control of Cervical
Cancer’s actions in the state of Maranhão and can con-
tribute to the recommendation of local actions. The as-
sociation between MHDI and the occurrence of CCAs
and HSIL+ shows that more developed areas with more
effective health services have a lower prevalence of these
lesions. Failed collections underscore the need for con-
stant and systematic monitoring of actions aimed at
achieving high-quality screening, which seems not to be
occurring despite an annual average of 227,282 samples
collected by the program. To increase the TZ represen-
tativeness and positivity index of samples, it is impera-
tive that investments be made in training and skill-
building for proper sample collection and analysis. Des-
pite being an opportunistic program, it is essential to
promote strategies for managers’, health professionals’
and users’ adherence to the guidelines recommended by
the Ministry of Health. Another aspect to be considered
is the formulation of policies to reduce social inequality
and improve the availability of health services aimed at
promoting well-being and social justice, as this would
result in the reduction of disparities in regard to access
to cervical cancer control strategies.
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